KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Current Assets (2016 - 2025)

Historic Current Assets for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $2.5 billion.

  • Ionis Pharmaceuticals' Current Assets fell 718.01% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 718.01%. This contributed to the annual value of $2.6 billion for FY2024, which is 81.62% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Current Assets of $2.5 billion as of Q3 2025, which was down 718.01% from $2.6 billion recorded in Q2 2025.
  • Ionis Pharmaceuticals' Current Assets' 5-year high stood at $2.7 billion during Q3 2024, with a 5-year trough of $2.0 billion in Q1 2021.
  • For the 5-year period, Ionis Pharmaceuticals' Current Assets averaged around $2.4 billion, with its median value being $2.4 billion (2024).
  • In the last 5 years, Ionis Pharmaceuticals' Current Assets plummeted by 2222.9% in 2021 and then soared by 2009.75% in 2023.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Current Assets stood at $2.3 billion in 2021, then fell by 6.07% to $2.2 billion in 2022, then increased by 19.94% to $2.6 billion in 2023, then decreased by 0.82% to $2.6 billion in 2024, then dropped by 3.87% to $2.5 billion in 2025.
  • Its Current Assets was $2.5 billion in Q3 2025, compared to $2.6 billion in Q2 2025 and $2.4 billion in Q1 2025.